[PDF][PDF] GR actions in stromal cells suppress inflammatory arthritis by induction of anti-inflammatory macrophages
M Koenen - 2019 - oparu.uni-ulm.de
Rheumatoid arthritis (RA) is a severe inflammatory autoimmune disease affecting
approximately 1% of the world's population and glucocorticoids (GCs) are still among the …
approximately 1% of the world's population and glucocorticoids (GCs) are still among the …
Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
M Koenen, S Culemann, S Vettorazzi… - Annals of the …, 2018 - ard.bmj.com
Background Glucocorticoid (GC) therapy is frequently used to treat rheumatoid arthritis due
to potent anti-inflammatory actions of GCs. Direct actions of GCs on immune cells were …
to potent anti-inflammatory actions of GCs. Direct actions of GCs on immune cells were …
Glucocorticoids suppress inflammation in arthritis via the glucocorticoid receptor in non-hematopoietic cells
U Baschant, S Culemann, M Koenen, H Zhou… - Bone …, 2014 - bone-abstracts.org
Owing to their anti-inflammatory effects, steroid therapy using glucocorticoids (GCs) is still
part of the treatment of rheumatoid arthritis (RA), despite several severe side effects like …
part of the treatment of rheumatoid arthritis (RA), despite several severe side effects like …
The glucocorticoid receptor (GR) orchestrates the crosstalk between fibroblast-like synoviocytes and macrophages to reduce Inflammation in arthritis
K Paxian, M Koenen, S Culemann, S Vettorazzi… - …, 2019 - thieme-connect.com
Results: Mice lacking GR and with hampered GR dimerization capacity in all cell types but
with intact GR in the hematopoietic compartment including circulating immune cells, showed …
with intact GR in the hematopoietic compartment including circulating immune cells, showed …
Studying the therapeutic benefit of a glucocorticoid receptor phytomodulator in synoviocytes derived from rheumatoid arthritis patients
V Gossye - 2009 - biblio.ugent.be
Rheumatoid arthritis (RA) is a chronic inflammatory ailment that is characterized by the
hyperproliferative and invasive nature of fibroblast-like synoviocytes (FLS). Although …
hyperproliferative and invasive nature of fibroblast-like synoviocytes (FLS). Although …
Origin and functional activity of the membrane‐bound glucocorticoid receptor
C Strehl, T Gaber, M Löwenberg… - Arthritis & …, 2011 - Wiley Online Library
Abstract Objective Glucocorticoids (GCs) exert their antiinflammatory and
immunosuppressive effects in humans primarily via the cytosolic GC receptor (cGR) but also …
immunosuppressive effects in humans primarily via the cytosolic GC receptor (cGR) but also …
THU0127 Functional activity of membrane-bound glucocorticoid receptors
C Strehl, T Gaber, M Jakstadt, M Hahne… - Annals of the …, 2013 - ard.bmj.com
Background Glucocorticoids are among the most commonly used anti-inflammatory and
immunosuppressive drugs in the treatment of rheumatic diseases. They exert their anti …
immunosuppressive drugs in the treatment of rheumatic diseases. They exert their anti …
Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells
U Baschant, L Frappart, U Rauchhaus… - Proceedings of the …, 2011 - National Acad Sciences
Despite several side effects, glucocorticoids (GCs) have been widely used for 60 y to treat
rheumatoid arthritis on the basis of their antiinflammatory effects. However, the cells targeted …
rheumatoid arthritis on the basis of their antiinflammatory effects. However, the cells targeted …
Novel mechanisms of action and new target genes of the glucocorticoid receptor in inflammatory bone disease and bone loss
Glucocorticoids (GCs) are widely used to treat chronic inflammatory diseases such as
rheumatoid (RA) and lead to multiple side effects including glucocorticoid induced …
rheumatoid (RA) and lead to multiple side effects including glucocorticoid induced …
Novel Mechanisms of the glucocorticoid receptor in inflammatory bone disease and bone loss
U Baschant, M Koenen, S Culemann… - Experimental and …, 2014 - thieme-connect.com
Glucocorticoids (GCs) are widely used to treat chronic inflammatory diseases such as
rheumatoid (RA) and lead to multiple side effects including GC induced osteoporosis (GIO) …
rheumatoid (RA) and lead to multiple side effects including GC induced osteoporosis (GIO) …